Molnupiravir for the treatment of non-severe COVID-19: a systematic review and meta-analysis of 14 randomized trials with 34 570 patients–authors’ response-Reference-Cited by-同舟云学术

Molnupiravir for the treatment of non-severe COVID-19: a systematic review and meta-analysis of 14 randomized trials with 34 570 patients–authors’ response

Published:2023-10-26 Issue:12 Volume:78 Page:3009-3012
ISSN:0305-7453
Container-title:Journal of Antimicrobial Chemotherapy
language:en
Short-container-title:

Author:

Sun Mingyao¹²,Lai Honghao³⁴,Zhang Zhigang¹²,Ge Long³⁴⁵

Affiliation:

1. Evidence-Based Nursing Center, School of Nursing, Lanzhou University , Lanzhou, Gansu , China

2. Department of Intensive Care Unit, The First Hospital of Lanzhou University , Lanzhou, Gansu , China

3. Evidence-Based Social Science Research Center, School of Public Health, Lanzhou University , Lanzhou, Gansu , China

4. Department of Social Medicine and Health Management, School of Public Health, Lanzhou University , Lanzhou, Gansu , China

5. Key Laboratory of Evidence-Based Medicine and Knowledge Translation of Gansu Province , Lanzhou, Gansu , China

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology,Microbiology (medical)

Link

https://academic.oup.com/jac/article-pdf/78/12/3009/53850299/dkad336.pdf

Reference7 articles.

1. Is molnupiravir a wise investment? Reassessing COVID-19 treatment strategies;Kow;J Antimicrob Chemother,2023

2. Comment on: ‘vitruvian plot: a visualisation tool for multiple outcomes in network meta-analysis’;Lai;Evid Based Ment Health,2022

3. Molnupiravir for the treatment of non-severe COVID-19: a systematic review and meta-analysis of 14 randomized trials with 34 570 patients;Sun;J Antimicrob Chemother,2023

4. A living WHO guideline on drugs for COVID-19;Lamontagne;BMJ,2020

5. Molnupiravir and nirmatrelvir-ritonavir reduce mortality risk during post-acute COVID-19 phase;Wan;J Infect,2023

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The emergence and implications of SARS-CoV-2 omicron subvariant BA.2.86 on global health;International Journal of Surgery;2024-01-11